Patents by Inventor Yoshinori Yoshida

Yoshinori Yoshida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220319777
    Abstract: A laminated electronic component includes an element body formed by laminating an insulating layer and having a bottom surface used as a mounting surface, and a bottom surface electrode formed on the bottom surface of the element body and containing glass and a sintered metal, wherein the bottom surface electrode includes a first electrode layer and a second electrode layer formed on the element body side from the first electrode layer, an edge portion of the second electrode layer is covered with an overcoat layer which is a part of the element body, the first electrode layer is laminated on the second electrode layer with the overcoat layer interposed therebetween, and a content of glass in the first electrode layer is larger than a content of glass in the second electrode layer.
    Type: Application
    Filed: March 22, 2022
    Publication date: October 6, 2022
    Applicant: TDK CORPORATION
    Inventors: Noriyuki SAITO, Osamu HIROSE, Toru YOSHIDA, Yoshinori SATO, Akira SUDA, Akira NAKAMURA
  • Publication number: 20220319767
    Abstract: A laminated electronic component includes an element body formed by laminating an insulating layer and having a bottom surface used as a mounting surface, and side surfaces configured to extend to intersect the bottom surface, and a bottom surface electrode formed on the bottom surface of the element body, wherein the bottom surface electrode includes a first electrode layer and a second electrode layer formed on the element body side from the first electrode layer, the first electrode layer is a resin electrode laminated to cover the second electrode layer, and has a stretched portion configured to extend to the side surface, and a width dimension of the stretched portion is smaller than a width dimension of the first electrode layer on the bottom surface.
    Type: Application
    Filed: March 30, 2022
    Publication date: October 6, 2022
    Applicant: TDK CORPORATION
    Inventors: Noriyuki SAITO, Yoshinori SATO, Toru YOSHIDA, Akira SUDA, Akira NAKAMURA
  • Publication number: 20220298482
    Abstract: As a technology for enriching atrial myocytes or ventricular myocytes in a cardiomyocyte-containing cell population induced from stem cells, provided is a method for enriching atrial myocytes or ventricular myocytes in a cardiomyocyte-containing cell population induced from stem cells, the method including a step of collecting atrial myocytes or ventricular myocytes from the cell population by using the expression level of CD151 as an index.
    Type: Application
    Filed: August 19, 2020
    Publication date: September 22, 2022
    Applicant: Orizuru Therapeutics, Inc.
    Inventors: Yoshinori YOSHIDA, Kenji MIKI, Misato KOAKUTSU
  • Publication number: 20220283186
    Abstract: The present disclosure provides a method for detecting Alzheimer's cognitive impairment or mild cognitive impairment, comprising: measuring an amount of homocysteic acid in a biological sample from a subject who suffers or possibly suffers from a neurological disease, and detecting Alzheimer's cognitive impairment or mild cognitive impairment based on the measured amount of the homocysteic acid.
    Type: Application
    Filed: August 28, 2020
    Publication date: September 8, 2022
    Applicant: NIPRO CORPORATION
    Inventors: Hiroshi YOSHIDA, Yoshinori KOSOKU, Yuka SANO
  • Publication number: 20220278286
    Abstract: Provided are: a compound capable of further improving the performance of organic EL devices, an organic electroluminescent device having more improved device performance, and an electronic apparatus including such an organic electroluminescent device. Precisely provided are: a compound represented by the following formula (1): wherein the symbols are as defined in the description, an organic electroluminescent device containing the compound, and an electronic apparatus including such an organic electroluminescent device.
    Type: Application
    Filed: February 24, 2022
    Publication date: September 1, 2022
    Applicant: IDEMITSU KOSAN CO.,LTD.
    Inventors: Kei YOSHIDA, Masato MITANI, Masatoshi SAITO, Sayaka MIZUTANI, Yoshinori AOYAMA
  • Patent number: 11401264
    Abstract: The present invention provides a heterocyclic compound having an activity to promote the maturation of a cardiomyocyte. A compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof has an activity to promote the maturation of a cardiomyocyte, and is useful as a cardiomyocyte maturation promoter.
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: August 2, 2022
    Assignee: Orizuru Therapeutics, Inc.
    Inventors: Yoshinori Yoshida, Kenji Miki, Akira Kaieda, Shigeru Kondo, Hiroshi Nara, Yoshinori Ikeura
  • Publication number: 20220234933
    Abstract: A screw-type separation device 1 includes a casing 10 including an object discharging port and discharging an object A having been dehydrated, and a separated liquid discharging port; a screw shaft provided inside the casing and extending in an extending direction that is a direction from the one end part to the other end part; a first screw blade extending spirally on an outer peripheral surface of the screw shaft; and a second screw blade extending spirally on the outer peripheral surface of the screw shaft such that a predetermined gap is formed with respect to the first screw blade in the extending direction. A groove is formed on an inner peripheral surface of the casing.
    Type: Application
    Filed: June 18, 2020
    Publication date: July 28, 2022
    Applicant: METAWATER CO., LTD.
    Inventors: Satoshi INOUE, Yoshitaka HASHIMOTO, Yoshinori ANDO, Takuya YOSHIDA
  • Publication number: 20220230945
    Abstract: A semiconductor device includes a base plate, a substrate, a semiconductor element, a case, and a wiring terminal. The case is disposed on the base plate so as to cover the substrate and the semiconductor element. The wiring terminal is electrically connected to the semiconductor element. The case includes a first case unit and a second case unit that is separate from the first case unit. The wiring terminal includes a first wiring unit and a second wiring unit. The first wiring unit is disposed so as to protrude from an inside to an outside of the case, and is electrically connected to the semiconductor element. The second wiring unit is bent with respect to the first wiring unit and disposed outside the case. The first case unit and the second case unit are disposed so as to sandwich the first wiring unit.
    Type: Application
    Filed: July 4, 2019
    Publication date: July 21, 2022
    Applicant: Mitsubishi Electric Corporation
    Inventors: Yuji SATO, Yoshinori YOKOYAMA, Motoru YOSHIDA, Jun FUJITA
  • Patent number: 11389457
    Abstract: The present invention relates to a method for preventing transmission of influenza, wherein said method comprises administering an effective amount of a compound to a patient having an influenza virus infection, herein referred to as “index patient”, wherein the compound has one of the formulae (I) and (II), or its pharmaceutically acceptable salt. The compound to be used in the present invention reduces infectivity of the influenza virus of the index patient, and therefore, reduces the risk of the index patient to trigger an influenza epidemic or an influenza pandemic as compared to a control patient.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: July 19, 2022
    Assignees: Hoffmann-La Roche Inc., Shionogi & Co., Ltd.
    Inventors: Takeshi Noshi, Takahiro Noda, Ryu Yoshida, Takao Shishido, Kaoru Baba, Aeron C. Hurt, Leo Yi Yang Lee, Steffen Wildum, Klaus Kuhlbusch, Barry Clinch, Jan Michal Nebesky, Annabelle Lemenuel, Wendy S. Barclay, Jean-Eric Charoin, Yoshinori Ando
  • Patent number: 11359180
    Abstract: Provided is a method for producing myocardial cells from pluripotent stem cells. The myocardial cell production method provided by the present invention includes supplying an artificially produced synthetic peptide to a cell culture that contains pluripotent stem cells. The synthetic peptide is a peptide that contains a myocardial cell differentiation-inducing peptide sequence that induces pluripotent stem cells into myocardial cells. The myocardial cell differentiation-inducing peptide sequence is an amino acid sequence selected from the group consisting of (i) an amino acid sequence constituting the signal peptide of any protein belonging to the amyloid precursor protein (APP) family, (ii) a partial amino acid sequence of the amino acid sequence according to (i), and (iii) a modified amino acid sequence from the amino acid sequence according to (i) or (ii).
    Type: Grant
    Filed: April 28, 2016
    Date of Patent: June 14, 2022
    Assignees: Toagosei Co., Ltd., Kyoto University
    Inventors: Tetsuhiko Yoshida, Kenichi Tanaka, Nahoko Baileykobayashi, Yoshinori Yoshida
  • Publication number: 20220145329
    Abstract: The present invention provides means which is excellent in efficiency with which a nucleic acid is introduced to cardiac muscle cells, especially a transfection method. A method for transfection of a nucleic acid into a cardiac muscle cell of the present invention comprises a step of contacting a composition comprising: a compound represented by the formula (I) or a salt thereof; a structured lipid; and a nucleic acid, with a cell population comprising cardiac muscle cells.
    Type: Application
    Filed: August 8, 2019
    Publication date: May 12, 2022
    Inventors: Yoshinori Yoshida, Kenji Miki, Satoru Matsumoto
  • Publication number: 20220005804
    Abstract: A semiconductor device with an insulated-gate field-effect transistor and its manufacturing method. The cell region EFR defined in the first region of one main surface side of semiconductor substrate (SUB), an insulated gate-type field-effect transistor (MFET) is formed, the gate pad region GPR defined in the first region, snubber circuit SNC is formed snubber region SNR is defined. Within the first and second regions, first and second deep trenches spaced apart from each other are formed, and at least one width of the plurality of second deep trenches formed in the second region is smaller than that of the first deep trench formed in the first region.
    Type: Application
    Filed: September 15, 2021
    Publication date: January 6, 2022
    Inventors: Fujio SHIMIZU, Tsuyoshi KACHI, Yoshinori YOSHIDA
  • Publication number: 20210363486
    Abstract: By using a drug that activates the cell cycle, including a retinoic acid receptor agonist, a phosphatidylinositol 3-kinase (PI3K) inhibiting agent, or an isocitrate dehydrogenase 1 (IDH1) inhibiting agent, cardiomyocytes can be made to propagate efficiently, and engraftment rate of cardiomyocytes can also be increased at the time of transplantation.
    Type: Application
    Filed: February 8, 2019
    Publication date: November 25, 2021
    Inventors: Yoshinori YOSHIDA, Takeshi HATANI, Manabu KASAMOTO, Shunsuke FUNAKOSHI
  • Patent number: 11181215
    Abstract: A pipe joint includes a hollow joint main body; a nut that is screwed into the joint main body; a seal member that is mounted to inside of the joint main body; and a retainer that is placed between the joint main body and the nut and comprises a pawl portion engaged with a trough of a metal flexible pipe in a coupled state and a retainer locking portion caught and locked inside of the joint main body in the coupled state.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: November 23, 2021
    Assignee: Hitachi Metals, Ltd.
    Inventors: Makoto Ibayashi, Yoshinori Yoshida, Takashi Toku, Takaaki Inotani
  • Patent number: 11152353
    Abstract: A semiconductor device with an insulated-gate field-effect transistor and its manufacturing method. The cell region EFR defined in the first region of one main surface side of semiconductor substrate (SUB), an insulated gate-type field-effect transistor (MFET) is formed, the gate pad region GPR defined in the first region, snubber circuit SNC is formed snubber region SNR is defined. Within the first and second regions, first and second deep trenches spaced apart from each other are formed, and at least one width of the plurality of second deep trenches formed in the second region is smaller than that of the first deep trench formed in the first region.
    Type: Grant
    Filed: April 17, 2020
    Date of Patent: October 19, 2021
    Assignee: RENESAS ELECTRONICS CORPORATION
    Inventors: Fujio Shimizu, Tsuyoshi Kachi, Yoshinori Yoshida
  • Publication number: 20210252074
    Abstract: Provided are a composition for cell transplant and a method for cell transplant, both of which enable a myocardial tissue to favorably retain cardiac myocytes and/or cardiac progenitors and can improve the persistence and proliferation of transplanted cells. The composition for cell transplant of the present invention is a composition for cell transplant, containing cells and an aqueous solution containing a protein (A), the cells including a cardiac myocyte and/or a cardiac progenitor, the protein (A) having a degree of hydrophobicity of 0.2 to 1.
    Type: Application
    Filed: May 9, 2019
    Publication date: August 19, 2021
    Applicants: KYOTO UNIVERSITY, SANYO CHEMICAL INDUSTRIES, LTD.
    Inventors: Yoshinori YOSHIDA, Takeshi HATANI, Ryosuke SUZUKI, Shingo KAWABATA
  • Patent number: 10981953
    Abstract: A method for promoting expression of calreticulin in at least one kind of eukaryotic cell, and a synthetic peptide useful in this method are provided. In the method provided by the present invention, a culture of target cells is prepared, and a calreticulin expression-promoting peptide having calreticulin expression-promoting activity is supplied at least once to that culture.
    Type: Grant
    Filed: December 24, 2014
    Date of Patent: April 20, 2021
    Assignees: TOAGOSEI CO, LTD., KYOTO UNIVERSITY
    Inventors: Nahoko Baileykobayashi, Tetsuhiko Yoshida, Yoshinori Yoshida, Kazuhisa Chonabayashi
  • Publication number: 20210054406
    Abstract: A production method comprising the step of forming an aggregate of cells under conditions that permit transfection of the cells with a substance in a non-cell-adhesive container is provided as a technique for producing cells having the desired substance introduced therein on a large scale at a commercial level.
    Type: Application
    Filed: March 28, 2019
    Publication date: February 25, 2021
    Applicants: Kyoto University, Takeda Pharmaceutical Company Limited
    Inventors: Yoshinori YOSHIDA, Kenji MIKI, Yasuharu KAMACHI
  • Publication number: 20210024512
    Abstract: The present invention provides a heterocyclic compound having an activity to promote the maturation of a cardiomyocyte. A compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof has an activity to promote the maturation of a cardiomyocyte, and is useful as a cardiomyocyte maturation promoter.
    Type: Application
    Filed: March 28, 2019
    Publication date: January 28, 2021
    Applicants: Kyoto University, Takeda Pharmaceutical Company Limited
    Inventors: Yoshinori YOSHIDA, Kenji MIKI, Akira KAIEDA, Shigeru KONDO, Hiroshi NARA, Yoshinori IKEURA
  • Patent number: D960381
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: August 9, 2022
    Assignee: JTEKT CORPORATION
    Inventors: Yuki Kobayashi, Yoshinobu Katoh, Hiromichi Ohta, Akihisa Umetani, Takeshi Koyama, Yoshinori Wada, Riku Nagayama, Madoka Hattori, Katsuhide Kikuchi, Shintaro Yoshida, Mikio Shinohara